UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis

PLoS neglected tropical diseases, 2013-11, Vol.7 (11), p.e2447-e2447

2013

Volltextzugriff (PDF)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

PLoS neglected tropical diseases, 2023-05, Vol.17 (5), p.e0011365-e0011365

2023

Volltextzugriff (PDF)

Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis

Clinical infectious diseases, 2016-02, Vol.62 (3), p.334-341

2016

Volltextzugriff (PDF)

Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature

PLoS neglected tropical diseases, 2018-05, Vol.12 (5), p.e0006454

2018

Volltextzugriff (PDF)

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections

PLoS neglected tropical diseases, 2022-05, Vol.16 (5), p.e0010407-e0010407

2022

Volltextzugriff (PDF)

Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study

The Lancet infectious diseases, 2017-04, Vol.17 (4), p.451-458

2017

Volltextzugriff (PDF)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

PLoS neglected tropical diseases, 2017-01, Vol.11 (1), p.e0005163-e0005163

2017

Volltextzugriff (PDF)

IgG4 antibodies to the recombinant filarial antigen Wb-Bhp-1 decrease dramatically following treatment of lymphatic filariasis

PLoS neglected tropical diseases, 2023-06, Vol.17 (6), p.e0011364-e0011364

2023

Volltextzugriff (PDF)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

PLoS neglected tropical diseases, 2021-03, Vol.15 (3), p.e0009294-e0009294

2021

Volltextzugriff (PDF)

A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis

PLoS neglected tropical diseases, 2021-03, Vol.15 (3), p.e0009002-e0009002

2021

Volltextzugriff (PDF)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

PLoS neglected tropical diseases, 2021-02, Vol.15 (2), p.e0009069-e0009069

2021

Volltextzugriff (PDF)

Human Paragonimiasis in North America following Ingestion of Raw Crayfish

Clinical infectious diseases, 2009-09, Vol.49 (6), p.e55-e61

2009

Volltextzugriff (PDF)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis

PLoS neglected tropical diseases, 2023-08, Vol.17 (8), p.e0011567

2023

Volltextzugriff (PDF)

Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin

BMC infectious diseases, 2022-11, Vol.22 (1), p.1-832, Article 832

2022

Volltextzugriff (PDF)

The proteome of extracellular vesicles of the lung fluke Paragonimus kellicotti produced in vitro and in the lung cyst

Scientific reports, 2023-08, Vol.13 (1), p.13726-13726, Article 13726

2023

Volltextzugriff (PDF)

Progress towards onchocerciasis elimination in Côte d'Ivoire: A geospatial modelling study

PLoS neglected tropical diseases, 2021-02, Vol.15 (2), p.e0009091

2021

Volltextzugriff (PDF)

High pressure freezing/freeze substitution fixation improves the ultrastructural assessment of Wolbachia endosymbiont-filarial nematode host interaction

PloS one, 2014-01, Vol.9 (1), p.e86383-e86383

2014

Volltextzugriff (PDF)

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study

PLoS neglected tropical diseases, 2023-09, Vol.17 (9), p.e0011633-e0011633

2023

Volltextzugriff (PDF)

Comparative proteomics of adult Paragonimus kellicotti excretion/secretion products released in vitro or present in the lung cyst nodule

PLoS neglected tropical diseases, 2022-08, Vol.16 (8), p.e0010679-e0010679

2022

Volltextzugriff (PDF)

Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis

PLoS neglected tropical diseases, 2019-10, Vol.13 (10), p.e0007762-e0007762

2019

Volltextzugriff (PDF)

The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo

PLoS neglected tropical diseases, 2020-06, Vol.14 (6), p.e0008322-e0008322

2020

Volltextzugriff (PDF)

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study

PLoS neglected tropical diseases, 2020-06, Vol.14 (6), p.e0008298

2020

Volltextzugriff (PDF)

Diagnostic tools for filariasis elimination programs

Trends in parasitology, 2007-02, Vol.23 (2), p.78-82

2007

Volltextzugriff (PDF)

Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d’Ivoire

PLoS neglected tropical diseases, 2020-09, Vol.14 (9), p.e0008642-e0008642

2020

Volltextzugriff (PDF)

North American paragonimiasis: epidemiology and diagnostic strategies

Expert review of anti-infective therapy, 2015-06, Vol.13 (6), p.779-786

2015

Volltextzugriff (PDF)

1 – 25 von 236

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

Englisch
(236)

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(166)
Animals
(110)
Humans
(104)
Infectious Diseases
(82)
Tropical Medicine
(80)
Parasitology
(77)
Female
(60)
Biological And Medical Sciences
(59)
Male
(56)
Filariasis
(46)
Tropical Diseases
(45)
Medical Sciences
(43)
Parasitic Diseases
(39)
Public, Environmental & Occupational Health
(36)
Brugia Malayi
(34)
Parasites
(34)
Infections
(30)
Ivermectin
(29)
Adult
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis

Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections

Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

IgG4 antibodies to the recombinant filarial antigen Wb-Bhp-1 decrease dramatically following treatment of lymphatic filariasis

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

Human Paragonimiasis in North America following Ingestion of Raw Crayfish

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis

Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin

The proteome of extracellular vesicles of the lung fluke Paragonimus kellicotti produced in vitro and in the lung cyst

Progress towards onchocerciasis elimination in Côte d'Ivoire: A geospatial modelling study

High pressure freezing/freeze substitution fixation improves the ultrastructural assessment of Wolbachia endosymbiont-filarial nematode host interaction

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study

Comparative proteomics of adult Paragonimus kellicotti excretion/secretion products released in vitro or present in the lung cyst nodule

Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis

The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study

Diagnostic tools for filariasis elimination programs

Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d’Ivoire

North American paragonimiasis: epidemiology and diagnostic strategies

Aktive Filter

Suchergebnisse filtern